GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Innova Captab Ltd (NSE:INNOVACAP) » Definitions » Revenue per Share

Innova Captab (NSE:INNOVACAP) Revenue per Share : ₹207.42 (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Innova Captab Revenue per Share?

Innova Captab's revenue per share for the three months ended in Dec. 2024 was ₹55.24. Innova Captab's revenue per share for the trailing twelve months (TTM) ended in Dec. 2024 was ₹207.42.

During the past 12 months, the average Revenue Per Share Growth Rate of Innova Captab was 12.10% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 43.80% per year. During the past 5 years, the average Revenue Per Share Growth Rate was 21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Innova Captab's Revenue per Share or its related term are showing as below:

NSE:INNOVACAP' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 17.5   Med: 19.6   Max: 43.8
Current: 43.8

During the past 6 years, Innova Captab's highest 3-Year average Revenue Per Share Growth Rate was 43.80% per year. The lowest was 17.50% per year. And the median was 19.60% per year.

NSE:INNOVACAP's 3-Year Revenue Growth Rate is ranked better than
93.7% of 905 companies
in the Drug Manufacturers industry
Industry Median: 5.9 vs NSE:INNOVACAP: 43.80

Innova Captab Revenue per Share Historical Data

The historical data trend for Innova Captab's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innova Captab Revenue per Share Chart

Innova Captab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Revenue per Share
Get a 7-Day Free Trial 94.60 71.57 139.76 161.71 212.99

Innova Captab Quarterly Data
Mar19 Mar20 Mar21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.85 45.14 51.41 55.63 55.24

Competitive Comparison of Innova Captab's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Innova Captab's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innova Captab's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Innova Captab's PS Ratio distribution charts can be found below:

* The bar in red indicates where Innova Captab's PS Ratio falls into.


;
;

Innova Captab Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Innova Captab's Revenue Per Share for the fiscal year that ended in Mar. 2024 is calculated as

Revenue Per Share (A: Mar. 2024 )=Revenue (A: Mar. 2024 )/Shares Outstanding (Diluted Average) (A: Mar. 2024 )
=10769.59/50.564
=212.99

Innova Captab's Revenue Per Share for the quarter that ended in Dec. 2024 is calculated as

Revenue Per Share (Q: Dec. 2024 )=Revenue (Q: Dec. 2024 )/Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
=3164.62/57.293
=55.24

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹207.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innova Captab  (NSE:INNOVACAP) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Innova Captab Revenue per Share Related Terms

Thank you for viewing the detailed overview of Innova Captab's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Innova Captab Business Description

Traded in Other Exchanges
Address
SCO No. 301, Sector 9, Second Floor, Panchkula, HR, IND, 134109
Innova Captab Ltd is an integrated pharmaceutical company in India and is engaged in research and development, manufacturing, drug distribution, and marketing and exports. Company business includes (i) a contract development and manufacturing organization ("CDMO") business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business, and (iii) an international branded generics business.

Innova Captab Headlines

No Headlines